John Lauerman
@LauermanJohn
Bloomberg News senior editor for health, science, medicine, hospitals etc. I have opinions, but RTs don't indicate them.
Here’s well put together/informative article by @jwgale about my #glioblastoma journey & novel treatment strategy formulated by friend/colleague @ProfGLongMIA & research generated by our @MelanomaAus team. Opinion leaders in field Roger Stupp, @Htwabi_MD & @mkhasraw even quoted!
This doctor was diagnosed with terminal brain cancer. Now he's helping to transform the treatment model trib.al/RggZmXq
Congratulations to Hanna Lauerman and everyone at Haley.henry for their nomination for a nationwide James Beard award in the Outstanding Wine program category. Judi and I love your servers, chefs, owner and especially the manager! jamesbeard.org/blog/the-2024-…
Verve Therapeutics gains after FDA lifts hold on its gene-editing therapy trial @gerryfsmith bloomberg.com/news/articles/…
Covid isn't the only virus that's long bloomberg.com/news/articles/… @jwgale
Biden responds to arguments against stricter SCOTUS ethics rules: “The idea that the Constitution would in any way prohibit or not encourage the court to have basic rules of ethics that are just on their face reasonable ... It’s just not the case.” propublica.org/article/biden-…
Companies that continue to market decongestants discredited by research are deceiving Americans, according Senator Marco Rubio. bloomberg.com/news/articles/… @cailleylapara
Step 1a is to make employees realize this.
The first step is to make CEOs realize the rebates they are getting, are paid for by their employees. It’s as if they think it’s free money. It’s not. If you are the CEO of a company that is getting rebates from your PBM, you have to understand that your employees are…
NEW: A key female chemist has been edged out of the Ozempic origin story. Svetlana Mojsov's experiences expose a disciplinary bias against chemists in favor of MDs and show how narratives of scientific discovery get passed down. From me and @MeganMolteni statnews.com/2023/09/27/wei…
Oh my God this is incredible.
CVS pharmacists in Kansas City locations are preparing to resume walkouts, saying the company reneged on a promise to make a public apology to workers and consumers for lack of service. bloomberg.com/news/articles/… @Fi_Rutherford @ikeswetlitz
On Plum Island, off the tip of Long Island’s North Fork, scientists study some of the most infectious pathogens known to man. But the center will soon be decommissioned and replaced by a new, billion-dollar facility in the middle of the country trib.al/iWsomXS
For the past 70 years, the Plum Island Animal Disease Center has been at the forefront of protecting the US livestock industry, and the population at-large. But now it's shutting down, to be replaced by a billion-dollar lab in the middle of Kansas. (2/4) bloomberg.com/news/features/…
Excessive hot weather is putting mothers at risk of severe pregnancy complications bloomberg.com/news/articles/… @cailliflower
Stanford's outgoing president starts correcting the research record bloomberg.com/news/articles/… @RobertLangreth
Health officials expected Covid to be seasonal, like flu. The virus didn't get the memo. bloomberg.com/news/articles/… @cailliflower
Feel bad for any dog -- or any animal -- that gets rabies bloomberg.com/news/articles/… @kristenvbrown
Excellent reporting from @jtozz on how PBM drug rebate contortions distort and inflate costs. “Documents and industry insiders suggest that PBMs’ pledges to pass the rebates they get from drugmakers back to their clients are a sleight of hand.” bloomberg.com/news/articles/…
"The median FTSE 100 CEO is now paid 118 times the median UK full-time worker" Oof. Not sure in what world this is healthy, or sustainable. At @kscopehealth we cap our top salary to 4x our lowest. Not without its issues, but zero plans to change it. theguardian.com/business/2023/…
Pfizer's RSV vaccine enters that chat bloomberg.com/news/articles/… @nncattan
With no treatments and little understanding of how it occurs, we'll be living with long Covid for a long time. bloomberg.com/news/articles/… @jwgale